10th Meet the Professor: Advanced International Breast Cancer Course (AIBCC)

Oncology Meeting Resources

06 Nov - 08 Nov, Padua, Italy

Nowadays, breast cancer represents the front runner in the path to comparative effectiveness, where new therapeutic interventions are implemented on the basis of "average" benefit, to personalised cancer medicine, where the right treatment is provided to the right patient at the right moment. An updated, multifaceted approach to our patients is now becoming more and more demanding and with these goals in mind, the Programme of this international Conference included lectures on molecular characterisation, updated management of early and advanced disease, strategies to overcome resistance to available therapies, innovative therapies, and multimodal treatments for advanced disease.

On this page, ESMO members may download the PDFs of presentations given at the 10th Meet the Professor: Advanced International Breast Cancer Course (AIBCC) to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful link

Presenter Presentation title Session title
Anna Sapino Standardization of breast cancer diagnosis: Pathology Pathology
Philip Poortmans Post-mastectomy radiotherapy: A new standard? Locoregional therapies: Evolving loco-regional management
Philip Poortmans Hypofractionated breast irradiation Locoregional therapies: Evolving loco-regional management
Pietro Panizza Surveillance of high-risk women Imaging: Role of MRI in breast cancer diagnosis
Pietro Panizza Pre-operative breast MRI Imaging: Role of MRI in breast cancer diagnosis
Pietro Panizza Breast MRI & NAC Imaging: Role of MRI in breast cancer diagnosis
Petra Steyerova Role of MRI in breast cancer diagnosis Imaging: Role of MRI in breast cancer diagnosis
Robert Coleman Is there a role for adjuvant bisphosphonates? Staging and adjuvant
Petra Boelens Do guidelines impact on patients outcome? Guidelines: Role of guidelines in the era of personalized cancer medicine
Valentina Guarneri Adjuvant therapy for low risk HER2+ patients Early Breast Cancer
Stephen Johnston Endocrine adjuvant therapy in premenopause Early Breast Cancer
Silvia Michieletto A case of triple negative breast cancer in young patient Neoadjuvant-Clinical case discussion II
Tania Saibene Locoregional management Neoadjuvant-Clinical case discussion II
Philip Poortmans Locoregional management Neoadjuvant-Clinical case discussion II
Stephen Johnston HR+/HER2 negative Neoadjuvant-Clinical case discussion II